A.R.T. Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
2018
Q2
$24K Buy
2018
Q1
Sell
2017
Q4
$110K Buy
2017
Q3
Sell
2017
Q2
$197K Buy
2017
Q1
$117K Buy
2016
Q2
Sell
2016
Q1
$832K Buy